Par, Fleming Drop Spat Over Nasal Spray Patent

By Leigh Kamping-Carder

Law360, New York (January 28, 2010, 1:25 PM ET) -- Par Pharmaceutical Inc. has agreed to drop a suit it filed against Fleming & Co. Pharmaceuticals claiming the rival drug company infringed its patent and intentionally misled consumers with the marketing of its prescription nasal spray, CaloMist.

With a single handwritten line, Judge Rodney W. Sippel of the U.S. District Court for the Eastern District of Missouri on Wednesday signed off on a stipulation the parties filed indicating they would dismiss their claims with prejudice.

Kurt D. Williams of Berkowitz Oliver Williams Shaw & Eisenbrandt LLP,...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles